All In Biotech

Drugs by condition

Drugs approved for chronic kidney disease

Brand-name prescription drugs and biologics whose FDA label lists chronic kidney disease as an approved use. Matched on the label phrases: "chronic kidney disease".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

27

Still marketed, NDA or BLA

Drug classes

9

Novel drugs

14

New molecular entities and new biologics

In development

30

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for chronic kidney disease.

  • Vafseo (Vadadustat) · Akebia NovelMar 27, 2024
  • Xphozah (Tenapanor Hydrochloride) · Ardelyx INC NovelOct 17, 2023
  • Inpefa (Sotagliflozin) · Lexicon Pharms INC NovelMay 26, 2023
  • Furoscix (Furosemide) · Scpharmaceuticals Oct 7, 2022
  • Korsuva (Difelikefalin Acetate) · Vifor Intl NovelBreakthrough therapyPriority reviewAug 23, 2021

All approved drugs for chronic kidney disease, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 56 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Sodium-Glucose Cotransporter 2 Inhibitor (4)

  • Inpefa Sotagliflozin · Lexicon Pharms INC · 2023
  • Jardiance Empagliflozin · Boehringer Ingelheim · 2014
  • Synjardy Xr Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
  • Synjardy Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2015

Parenteral Iron Replacement (3)

  • Ferrlecit Sodium Ferric Gluconate Complex · Sanofi Aventis US · 1999
  • Feraheme Ferumoxytol · Azurity · 2009
  • Venofer Iron Sucrose · Am Regent · 2000

Vitamin D2 Analog (2)

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (1)

  • Vafseo Vadadustat · Akebia · 2024

Nonsteroidal Mineralocorticoid-Receptor Antagonist (1)

  • Kerendia Finerenone · Bayer Hlthcare · 2021

Erythropoiesis-stimulating Agent (1)

  • Aranesp Darbepoetin Alfa · Amgen · 2001

Loop Diuretic (1)

  • Furoscix Furosemide · Scpharmaceuticals · 2022

Phosphate Binder (1)

  • Velphoro Ferric Oxyhydroxide · Vifor Fresenius · 2013

Class not listed in FDA's data (13)

  • Xphozah Tenapanor Hydrochloride · Ardelyx INC · 2023
  • Korsuva Difelikefalin Acetate · Vifor Intl · 2021
  • Ozempic Semaglutide · Novo · 2017
  • Parsabiv Etelcalcetide · Kai Pharms INC · 2017
  • Farxiga Dapagliflozin · Astrazeneca Ab · 2014
  • Mircera Methoxy Polyethylene Glycol-Epoetin Beta · Hoffman-La Roche · 2007
  • Epogen/Procrit Epoetin Alfa · Amgen · 1989
  • Monoferric Ferric Derisomaltose · Pharmacosmos · 2020
  • Retacrit Epoetin Alfa-Epbx · Hospira INC · 2018
  • Rayaldee Calcifediol · Eirgen · 2016
  • Xigduo Xr Dapagliflozin, Metformin Hydrochloride · Astrazeneca Ab · 2014
  • Auryxia Ferric Citrate · Keryx Biopharms · 2014
  • Injectafer Ferric Carboxymaltose · Am Regent · 2013

Drugs in development for chronic kidney disease

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CagrilintidePhase 320 trials

    Novo Nordisk · Obesity, Overweight, Type 2 Diabetes

  • RetatrutideLY3437943Phase 316 trials

    Eli Lilly · Obesity, Overweight, Type 2 Diabetes

  • HRS-7535Phase 310 trials

    Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

  • UBT251Phase 310 trials

    The United Bio-Technology (Hengqin) Co., Ltd. · Obesity, Obesity &Amp; Overweight, Diabetes Mellitus, Type 2

  • ElecoglipronPhase 39 trials

    AstraZeneca · Type 2 Diabetes Mellitus, Obesity, Overweight

  • ZenagamtidePhase 39 trials

    Novo Nordisk · Obesity, Overweight, Type 2 Diabetes

  • AND017Phase 36 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, β -Thalassemia, Cancer-Related Anemia

  • lorundrostatPhase 35 trials

    Mineralys Therapeutics Inc. · Hypertension, Obstructive Sleep Apnea, Chronic Kidney Disease

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • ESAErythropoiesis-Stimulating AgentPhase 33 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, Anemia of Chronic Kidney Disease

  • HRS-1780Phase 33 trials

    Shandong Suncadia Medicine Co., Ltd. · Chronic Kidney Disease, Uncontrolled or Resistant Hypertension, Primary Aldosteronism

  • MT1013Phase 33 trials

    Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis, Secondary Hyperparathyroidism, Chronic Kidney Disease

  • PacibekitugTOUR006, PAC001Phase 33 trials

    Tourmaline Bio, Inc., a Novartis Company · Myocardial Infarction, Thyroid Eye Disease, Chronic Kidney Diseases

  • PLS240upacicalcetPhase 33 trials

    Pathalys Pharma · Secondary Hyperparathyroidism, Chronic Kidney Disease (CKD), End-stage Kidney Disease (ESKD)

  • ABP-671Phase 32 trials

    Atom Therapeutics Co., Ltd · Chronic Kidney Disease, Gout

  • AP301Solnatide for reconstitution for forPhase 32 trials

    Alebund Pharmaceuticals · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease)

  • QRX-3EseronatePhase 32 trials

    Ebima Clifford Okundaye · Chronic Kidney Diseases, Acute Kidney Injury, Kidney Failure

  • rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials

    Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus

  • RoxadustatFG-4592, ASP1517Phase 32 trials

    Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes

  • SAL0120Phase 32 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Chronic Kidney Disease, Uncontrolled Hypertension, Resistant Hypertension

6 discontinued brand-name drugs whose label still names it

More on chronic kidney disease: recruiting trials · published research

Related in kidney and urology: IgA nephropathy · Overactive bladder · Enlarged prostate (BPH) · Erectile dysfunction

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.